Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2016-02-29 AGM Information
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information Classification · 1% confidence The document is titled "Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)" which translates to 'Notice of Extraordinary General Meeting in NeuroVive Pharmaceutical AB (publ)'. It details the date, time, location, registration procedures, agenda items (including proposals for amending the articles of association and approving a rights issue/share issue), and voting requirements for an upcoming shareholder meeting. This content directly corresponds to the purpose of a notice for a general meeting, which often includes proposals requiring shareholder approval. While it relates to a meeting, the primary function is to call the meeting and present the items for vote, making it highly relevant to the AGM process. Since the document is a formal notice calling for a meeting where specific corporate actions (like a capital increase) will be voted upon, it is best classified as related to the Annual General Meeting process. The code 'AGM-R' covers 'Presentations and materials shared during the Annual General Meeting (AGM)', and an official notice for an Extraordinary General Meeting (EGM) falls under this umbrella of meeting materials.
2016-02-29 Swedish
Notice of extraordinary general meeting in NeuroVive Pharmaceutical AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of extraordinary general meeting in NeuroVive Pharmaceutical AB (publ)". It details the date, time, location, registration requirements, agenda, and proposed resolutions for this meeting. The proposed resolutions involve amending the articles of association and approving a rights issue (issuing new shares and warrants). This content is characteristic of materials prepared for a shareholder meeting, specifically an Extraordinary General Meeting (EGM). While it contains proposals for capital changes (CAP), the primary context and structure are that of a formal meeting notice. The closest category covering meeting notices and related materials is AGM-R (AGM Information), which serves as the general category for General Meeting materials, even if it is an EGM. It is not a DEF 14A (Remuneration) or a DVA (Voting Results), as it is the notice *before* the vote.
2016-02-29 English
Styrelsen utser Erik Kinnman till ny VD för NeuroVive
Board/Management Information Classification · 1% confidence The document is explicitly titled "PRESSMEDDELANDE" (Press Release) and announces a significant management change: the appointment of Erik Kinnman as the new CEO, effective March 14, 2016. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. The document is short and functions as an immediate public announcement rather than a comprehensive report (like 10-K or IR).
2016-02-23 Swedish
Board Selects New CEO Erik Kinnman to Lead NeuroVive
Board/Management Information Classification · 1% confidence The document is explicitly titled "NEWS RELEASE" and announces a significant change in senior leadership: the selection of Erik Kinnman as the new Chief Executive Officer (CEO). This directly corresponds to the definition of Board/Management Information, which covers announcements of changes in senior management. The document is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Therefore, the appropriate classification is MANG.
2016-02-23 English
Earnings Release 2015
Earnings Release Classification · 1% confidence The document is titled "Bokslutskommuniké 2015" (Year-End Report Communication 2015) and provides detailed financial results for the Fourth Quarter (Q4) and the Full Year (2015-01-01 – 2015-12-31), including Net Sales, Profit/Loss before tax, Earnings per Share, balance sheet figures (Solidity, Equity, Cash), and cash flow statements. This structure is characteristic of a comprehensive periodic financial report covering a full fiscal year, which aligns with the definition of an Annual Report (10-K) or a comprehensive Interim/Quarterly Report (IR). Since it covers the full year ('Hela året') and contains detailed financial statements and management commentary, it is best classified as the comprehensive annual financial disclosure. Although the Swedish term 'Bokslutskommuniké' often precedes the formal 10-K filing, in the context of the provided definitions, it functions as the primary annual financial report content, making '10-K' the most appropriate fit for a comprehensive annual financial disclosure, or 'IR' if it were only a half-year report. Given it covers the full year, '10-K' is selected as the closest equivalent for a full-year financial report. Q4 2015
2016-02-19 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Year End Report 2015' and covers the financial performance for the fourth quarter and the full twelve months of 2015. It contains detailed financial statements, including net revenues, loss before tax, earnings per share, and a breakdown of operating results, as well as management commentary on business operations and strategy. Since it provides comprehensive financial data for a period shorter than a full fiscal year (specifically the Q4 and full-year results), it fits the definition of an Interim/Quarterly Report. FY 2015
2016-02-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.